Skandinaviska Enskilda Banken Ab (Publ) Catalyst Pharmaceuticals, Inc. Put Options Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $22.4 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CPRX
# of Institutions
385Shares Held
103MCall Options Held
0Put Options Held
277K-
Black Rock Inc. New York, NY18.7MShares$380 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.77MShares$178 Million0.0% of portfolio
-
State Street Corp Boston, MA5.48MShares$111 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.25MShares$66.1 Million0.1% of portfolio
-
Morgan Stanley New York, NY3.18MShares$64.8 Million0.0% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.09B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...